Trials / Sponsors / Holy Stone Healthcare Co., Ltd
Holy Stone Healthcare Co., Ltd
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Phase 2 Study of CA102N Combined With TAS-102 Compared to Bevacizumab Combined With TAS-102 in Subjects With R Metastatic Colorectal Cancer | Phase 2 | 2024-01-01 |
| Completed | First-in-human Study of CA102N Monotherapy and CA102N Combined With Trifluridine/Tipiracil (LONSURF) in Subjec Advanced or Metastatic Solid Tumors, Advanced or Metastatic Colorectal Cancer (mCRC) | Phase 1 | 2019-04-09 |
| Completed | A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M Colitis, Ulcerative | Phase 2 | 2016-01-01 |
| Completed | Pharmacokinetics of IBD98-M 400mg-57.5/Day in Healthy Volunteers Healthy | Phase 1 | 2014-07-01 |
| Temporarily Not Available | Individual Patient Expanded Access to CA102N Advanced or Metastatic Colorectal Cancer (mCRC) | — | — |